[Effect of thymosin alpha 1 on prostaglandin release by murine lymphocytes].
Baldassarre. A M AM; Stirparo. G G; Palamara. A T AT; Padovani. A A; Mastino. A A
Key Findings
- Thymosin‑alpha‑1 quickly (15 min) boosts PGE2 release from splenocytes of thymectomized mice at 4 µg/mL
- Longer exposure (60‑180 min) and higher doses (4‑8 µg/mL) further increase PGE2 release from these splenocytes
- Thymocytes need longer incubation to release the most PGE2, while lymphocytes from normal mice show little change
Practical Outcomes
- The data hint that thymosin‑alpha‑1 can influence prostaglandin pathways, which might affect inflammation or immune signaling. However, the study is in vitro with mouse cells, uses specific doses, and shows no clear benefit for human use, so it doesn’t provide a ready‑to‑apply protocol for biohackers.
Summary
In a mouse study, the peptide thymosin‑alpha‑1 caused certain immune cells to release the signaling molecule PGE2, especially in mice without a thymus and when the cells were exposed for longer periods. Normal mice didn’t show the same effect, indicating the response depends on the animal’s immune status.
Abstract
The effects on PGE2 release by lymphocytes obtained from adult thymectomized mice and from normal mice, after incubation with Thymosin alpha 1, were studied. Splenocytes from Tx mice release PGE2 at short time of incubation (15') using 4 micrograms/ml of Thymosin alpha 1 and at longer time of incubation (60'-180' using 4-8 micrograms/ml of Thymosin alpha 1. On the other hand thymocytes release the highest amounts of PGE2 after longer time of incubation (60'-180'). However lymphocytes obtained from normal mice do not release PGE2 amounts comparable with that released by the control samples. This effect shows an interesting interaction between thymic hormones and PGs.
Study Information
pubmed
1985
1985-01-30T00:00:00.000Z